Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal
Goldman Sachs acquired approximately 11 lakh shares of TD Power Systems in a block deal valued at Rs 50.30 crore, purchasing them at Rs 460
May 22, 2025